Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling

Abstract

BackgroundProfound chemoresistance remains an intractable obstacle in pancreatic cancer treatment. Pancreatic cancer stem cells (CSCs) and the ubiquitous hypoxic niche have been proposed to account for drug resistance. However, the mechanism involved requires further exploration. This study investigated whether the hypoxic niche enhances gemcitabine-induced stemness and acquired resistance in pancreatic cancer cells by activating the AKT/Notch1 signaling cascade. The therapeutic effects of blockading this signaling cascade on gemcitabine-enriched CSCs were also investigated.MethodsThe expression levels of CSC-associated markers Bmi1 and Sox2 as well as those of proteins involved in AKT/Notch1 signaling were measured by Western blot analysis. The expression level of the pancreatic CSC marker CD24 was measured by flow cytometry. Change in gemcitabine sensitivity was evaluated by the MTT assay. The ability of sphere formation was tested by the sphere-forming assay in stem cell medium. The ability of migration and invasion was detected by the transwell migration/invasion assay. A mouse xenograft model of pancreatic cancer was established to determine the effect of Notch1 inhibition on the killing effect of gemcitabine in vivo. The ability of metastasis was investigated by an in vivo lung metastasis assay.ResultsGemcitabine promoted pancreatic cancer cell stemness and associated malignant phenotypes such as enhanced migration, invasion, metastasis, and chemoresistance. The AKT/Notch1 signaling cascade was activated after gemcitabine treatment and mediated this process. Blockading this pathway enhanced the killing effect of gemcitabine in vivo. However, supplementation with hypoxia treatment synergistically enhanced the AKT/Notch1 signaling pathway and collaboratively promoted gemcitabine-induced stemness.ConclusionsThese findings demonstrate a novel mechanism of acquired gemcitabine resistance in pancreatic cancer cells through induction of stemness, which was mediated by the activation of AKT/Notch1 signaling and synergistically aggravated by the ubiquitous hypoxic niche. Our results might provide new insights for identifying potential targets for reversing chemoresistance in patients with pancreatic cancer.Electronic supplementary materialThe online version of this article (10.1186/s13046-018-0972-3) contains supplementary material, which is available to authorized users.

Retinoic Acid Sensitivity of Triple-Negative Breast-Cancer Cells Characterized by Constitutive Activation of the NOTCH1 Pathway: The Role of RARβ

“…Thus, ATRA is likely to target as yet unrecognized elements of the pathway laying downstream of the NOTCH1 protein in MB-157 cells. Given the role played by NOTCH proteins in the control of Epithelial-to-Mesenchymal-Transition (EMT) (43)(44) and the homeostasis of cancer stem-cells (10) , (45) (46), it is likely that ATRA down-modulates both processes (47) , (48) , (49). This is consistent with the differentiating effect of the retinoid and it may result in a reduction of the cancer stem-cell component of mammary tumours.…”

TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer

“…SOX2 is one of the key members of the SOX family gene and plays a critical role in the maintenance of the self-renewal and pluripotency of embryonic stem cells (44). Studies have revealed that SOX2 is an oncogene known to be ampli ed and overexpressed in carcinogenesis, metastasis and recurrence in many cancer types (45,46).…”

MicroRNA‑137 exerts protective effects on hypoxia‑induced cell injury by inhibiting autophagy/mitophagy and maintaining mitochondrial function in breast cancer stem‑like cells

“…HIFs are composed of an alpha (HIF-α) and a beta (HIF-β) subunit, and the oxygen-dependent HIF-α subunit is the key protein determining the transcriptional activity of HIFs, while the HIF-β subunit is structurally expressed in the cell nucleus (19). A large number of reports have revealed that oxygen deficit induces the generation of HIFs in human embryonic stem cells (hESCs), which have the ability to activate the Wnt and Notch self-renewal signaling pathways (20,21) and vascular endothelial growth factors (VEGFs) so that HIFs can maintain cells in an undifferentiated state and promote tumor vessel formation (22). MicroRNAs (miRNAs or miRs) are small noncoding single-stranded RNAs with a length of 22 nucleotides that affect the regulation of posttranscriptional gene expression (23).…”